Global Rotavirus Vaccines Market Insights and Forecast to 2031

Report ID: 1197240 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Rotavirus Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Rotavirus Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Rotarix
        1.2.3 RotaTeq
        1.2.4 Rotavac
        1.2.5 Rotavin-M1
        1.2.6 Lanzhou lamb
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Rotavirus Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Adult
        1.3.3 Pediatric
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Rotavirus Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Rotavirus Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Rotavirus Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Rotavirus Vaccines Sales by Region
        2.4.1 Global Rotavirus Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Rotavirus Vaccines by Region (2023-2028)
    2.5 Global Rotavirus Vaccines Revenue by Region
        2.5.1 Global Rotavirus Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Rotavirus Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Rotavirus Vaccines Sales by Manufacturers
        3.1.1 Global Top Rotavirus Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Rotavirus Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rotavirus Vaccines in 2021
    3.2 Global Rotavirus Vaccines Revenue by Manufacturers
        3.2.1 Global Rotavirus Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Rotavirus Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Rotavirus Vaccines Revenue in 2021
    3.3 Global Rotavirus Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Rotavirus Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Rotavirus Vaccines Sales by Type
        4.1.1 Global Rotavirus Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Rotavirus Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Rotavirus Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Rotavirus Vaccines Revenue by Type
        4.2.1 Global Rotavirus Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Rotavirus Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Rotavirus Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Rotavirus Vaccines Price by Type
        4.3.1 Global Rotavirus Vaccines Price by Type (2017-2022)
        4.3.2 Global Rotavirus Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Rotavirus Vaccines Sales by Application
        5.1.1 Global Rotavirus Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Rotavirus Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Rotavirus Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Rotavirus Vaccines Revenue by Application
        5.2.1 Global Rotavirus Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Rotavirus Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Rotavirus Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Rotavirus Vaccines Price by Application
        5.3.1 Global Rotavirus Vaccines Price by Application (2017-2022)
        5.3.2 Global Rotavirus Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Rotavirus Vaccines Market Size by Type
        6.1.1 North America Rotavirus Vaccines Sales by Type (2017-2028)
        6.1.2 North America Rotavirus Vaccines Revenue by Type (2017-2028)
    6.2 North America Rotavirus Vaccines Market Size by Application
        6.2.1 North America Rotavirus Vaccines Sales by Application (2017-2028)
        6.2.2 North America Rotavirus Vaccines Revenue by Application (2017-2028)
    6.3 North America Rotavirus Vaccines Market Size by Country
        6.3.1 North America Rotavirus Vaccines Sales by Country (2017-2028)
        6.3.2 North America Rotavirus Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Rotavirus Vaccines Market Size by Type
        7.1.1 Europe Rotavirus Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Rotavirus Vaccines Revenue by Type (2017-2028)
    7.2 Europe Rotavirus Vaccines Market Size by Application
        7.2.1 Europe Rotavirus Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Rotavirus Vaccines Revenue by Application (2017-2028)
    7.3 Europe Rotavirus Vaccines Market Size by Country
        7.3.1 Europe Rotavirus Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Rotavirus Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Rotavirus Vaccines Market Size by Type
        8.1.1 Asia Pacific Rotavirus Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Rotavirus Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Rotavirus Vaccines Market Size by Application
        8.2.1 Asia Pacific Rotavirus Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Rotavirus Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Rotavirus Vaccines Market Size by Region
        8.3.1 Asia Pacific Rotavirus Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Rotavirus Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Rotavirus Vaccines Market Size by Type
        9.1.1 Latin America Rotavirus Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Rotavirus Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Rotavirus Vaccines Market Size by Application
        9.2.1 Latin America Rotavirus Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Rotavirus Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Rotavirus Vaccines Market Size by Country
        9.3.1 Latin America Rotavirus Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Rotavirus Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Rotavirus Vaccines Market Size by Type
        10.1.1 Middle East and Africa Rotavirus Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Rotavirus Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Rotavirus Vaccines Market Size by Application
        10.2.1 Middle East and Africa Rotavirus Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Rotavirus Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Rotavirus Vaccines Market Size by Country
        10.3.1 Middle East and Africa Rotavirus Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Rotavirus Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bharat Biotech
        11.1.1 Bharat Biotech Corporation Information
        11.1.2 Bharat Biotech Overview
        11.1.3 Bharat Biotech Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bharat Biotech Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bharat Biotech Recent Developments
    11.2 Merck & Co., Inc
        11.2.1 Merck & Co., Inc Corporation Information
        11.2.2 Merck & Co., Inc Overview
        11.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck & Co., Inc Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck & Co., Inc Recent Developments
    11.3 GlaxoSmithKline plc
        11.3.1 GlaxoSmithKline plc Corporation Information
        11.3.2 GlaxoSmithKline plc Overview
        11.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GlaxoSmithKline plc Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GlaxoSmithKline plc Recent Developments
    11.4 Lanzhou Institute of Biological
        11.4.1 Lanzhou Institute of Biological Corporation Information
        11.4.2 Lanzhou Institute of Biological Overview
        11.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Lanzhou Institute of Biological Recent Developments
    11.5 Bharat Biotech International Limited
        11.5.1 Bharat Biotech International Limited Corporation Information
        11.5.2 Bharat Biotech International Limited Overview
        11.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Bharat Biotech International Limited Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Bharat Biotech International Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Rotavirus Vaccines Industry Chain Analysis
    12.2 Rotavirus Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Rotavirus Vaccines Production Mode & Process
    12.4 Rotavirus Vaccines Sales and Marketing
        12.4.1 Rotavirus Vaccines Sales Channels
        12.4.2 Rotavirus Vaccines Distributors
    12.5 Rotavirus Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Rotavirus Vaccines Industry Trends
    13.2 Rotavirus Vaccines Market Drivers
    13.3 Rotavirus Vaccines Market Challenges
    13.4 Rotavirus Vaccines Market Restraints
14 Key Findings in The Global Rotavirus Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Rotavirus Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Rotarix
    Table 3. Major Manufacturers of RotaTeq
    Table 4. Major Manufacturers of Rotavac
    Table 5. Major Manufacturers of Rotavin-M1
    Table 6. Major Manufacturers of Lanzhou lamb
    Table 7. Major Manufacturers of Others
    Table 8. Global Rotavirus Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Rotavirus Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Rotavirus Vaccines Sales by Region (2017-2022) & (K Units)
    Table 11. Global Rotavirus Vaccines Sales Market Share by Region (2017-2022)
    Table 12. Global Rotavirus Vaccines Sales by Region (2023-2028) & (K Units)
    Table 13. Global Rotavirus Vaccines Sales Market Share by Region (2023-2028)
    Table 14. Global Rotavirus Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Rotavirus Vaccines Revenue Market Share by Region (2017-2022)
    Table 16. Global Rotavirus Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Rotavirus Vaccines Revenue Market Share by Region (2023-2028)
    Table 18. Global Rotavirus Vaccines Sales by Manufacturers (2017-2022) & (K Units)
    Table 19. Global Rotavirus Vaccines Sales Share by Manufacturers (2017-2022)
    Table 20. Global Rotavirus Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Rotavirus Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 22. Rotavirus Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 23. Global Rotavirus Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Rotavirus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Vaccines as of 2021)
    Table 25. Rotavirus Vaccines Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Rotavirus Vaccines Product Offered
    Table 27. Date of Manufacturers Enter into Rotavirus Vaccines Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
    Table 30. Global Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
    Table 31. Global Rotavirus Vaccines Sales Share by Type (2017-2022)
    Table 32. Global Rotavirus Vaccines Sales Share by Type (2023-2028)
    Table 33. Global Rotavirus Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Rotavirus Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Rotavirus Vaccines Revenue Share by Type (2017-2022)
    Table 36. Global Rotavirus Vaccines Revenue Share by Type (2023-2028)
    Table 37. Rotavirus Vaccines Price by Type (2017-2022) & (USD/Unit)
    Table 38. Global Rotavirus Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 39. Global Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
    Table 40. Global Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
    Table 41. Global Rotavirus Vaccines Sales Share by Application (2017-2022)
    Table 42. Global Rotavirus Vaccines Sales Share by Application (2023-2028)
    Table 43. Global Rotavirus Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Rotavirus Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Rotavirus Vaccines Revenue Share by Application (2017-2022)
    Table 46. Global Rotavirus Vaccines Revenue Share by Application (2023-2028)
    Table 47. Rotavirus Vaccines Price by Application (2017-2022) & (USD/Unit)
    Table 48. Global Rotavirus Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 49. North America Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
    Table 50. North America Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
    Table 51. North America Rotavirus Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Rotavirus Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
    Table 54. North America Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
    Table 55. North America Rotavirus Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Rotavirus Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
    Table 58. North America Rotavirus Vaccines Sales by Country (2023-2028) & (K Units)
    Table 59. North America Rotavirus Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Rotavirus Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
    Table 62. Europe Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
    Table 63. Europe Rotavirus Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Rotavirus Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
    Table 66. Europe Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
    Table 67. Europe Rotavirus Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Rotavirus Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
    Table 70. Europe Rotavirus Vaccines Sales by Country (2023-2028) & (K Units)
    Table 71. Europe Rotavirus Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Rotavirus Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
    Table 74. Asia Pacific Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
    Table 75. Asia Pacific Rotavirus Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Rotavirus Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
    Table 78. Asia Pacific Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
    Table 79. Asia Pacific Rotavirus Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Rotavirus Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Rotavirus Vaccines Sales by Region (2017-2022) & (K Units)
    Table 82. Asia Pacific Rotavirus Vaccines Sales by Region (2023-2028) & (K Units)
    Table 83. Asia Pacific Rotavirus Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Rotavirus Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
    Table 86. Latin America Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
    Table 87. Latin America Rotavirus Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Rotavirus Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
    Table 90. Latin America Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
    Table 91. Latin America Rotavirus Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Rotavirus Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
    Table 94. Latin America Rotavirus Vaccines Sales by Country (2023-2028) & (K Units)
    Table 95. Latin America Rotavirus Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Rotavirus Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
    Table 98. Middle East and Africa Rotavirus Vaccines Sales by Type (2023-2028) & (K Units)
    Table 99. Middle East and Africa Rotavirus Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Rotavirus Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
    Table 102. Middle East and Africa Rotavirus Vaccines Sales by Application (2023-2028) & (K Units)
    Table 103. Middle East and Africa Rotavirus Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Rotavirus Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
    Table 106. Middle East and Africa Rotavirus Vaccines Sales by Country (2023-2028) & (K Units)
    Table 107. Middle East and Africa Rotavirus Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Rotavirus Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Bharat Biotech Corporation Information
    Table 110. Bharat Biotech Description and Major Businesses
    Table 111. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Bharat Biotech Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Bharat Biotech Recent Developments
    Table 114. Merck & Co., Inc Corporation Information
    Table 115. Merck & Co., Inc Description and Major Businesses
    Table 116. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Merck & Co., Inc Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Merck & Co., Inc Recent Developments
    Table 119. GlaxoSmithKline plc Corporation Information
    Table 120. GlaxoSmithKline plc Description and Major Businesses
    Table 121. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. GlaxoSmithKline plc Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. GlaxoSmithKline plc Recent Developments
    Table 124. Lanzhou Institute of Biological Corporation Information
    Table 125. Lanzhou Institute of Biological Description and Major Businesses
    Table 126. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Lanzhou Institute of Biological Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Lanzhou Institute of Biological Recent Developments
    Table 129. Bharat Biotech International Limited Corporation Information
    Table 130. Bharat Biotech International Limited Description and Major Businesses
    Table 131. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Bharat Biotech International Limited Rotavirus Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Bharat Biotech International Limited Recent Developments
    Table 134. Key Raw Materials Lists
    Table 135. Raw Materials Key Suppliers Lists
    Table 136. Rotavirus Vaccines Distributors List
    Table 137. Rotavirus Vaccines Customers List
    Table 138. Rotavirus Vaccines Market Trends
    Table 139. Rotavirus Vaccines Market Drivers
    Table 140. Rotavirus Vaccines Market Challenges
    Table 141. Rotavirus Vaccines Market Restraints
    Table 142. Research Programs/Design for This Report
    Table 143. Key Data Information from Secondary Sources
    Table 144. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rotavirus Vaccines Product Picture
    Figure 3. Global Rotavirus Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Rotarix Product Picture
    Figure 4. RotaTeq Product Picture
    Figure 5. Rotavac Product Picture
    Figure 6. Rotavin-M1 Product Picture
    Figure 7. Lanzhou lamb Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Rotavirus Vaccines Market Share by Application in 2021 & 2028
    Figure 10. Adult
    Figure 11. Pediatric
    Figure 12. Rotavirus Vaccines Report Years Considered
    Figure 13. Global Rotavirus Vaccines Sales 2017-2028 (K Units)
    Figure 14. Global Rotavirus Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Rotavirus Vaccines Revenue 2017-2028 (US$ Million)
    Figure 16. Global Rotavirus Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Rotavirus Vaccines Sales Market Share by Region (2017-2022)
    Figure 18. Global Rotavirus Vaccines Sales Market Share by Region (2023-2028)
    Figure 19. North America Rotavirus Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Rotavirus Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Rotavirus Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Rotavirus Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Rotavirus Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Rotavirus Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Rotavirus Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Rotavirus Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Rotavirus Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Rotavirus Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Rotavirus Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Rotavirus Vaccines in the World: Market Share by Rotavirus Vaccines Revenue in 2021
    Figure 31. Global Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Rotavirus Vaccines Sales Market Share by Type (2017-2028)
    Figure 33. Global Rotavirus Vaccines Revenue Market Share by Type (2017-2028)
    Figure 34. Global Rotavirus Vaccines Sales Market Share by Application (2017-2028)
    Figure 35. Global Rotavirus Vaccines Revenue Market Share by Application (2017-2028)
    Figure 36. North America Rotavirus Vaccines Sales Market Share by Type (2017-2028)
    Figure 37. North America Rotavirus Vaccines Revenue Market Share by Type (2017-2028)
    Figure 38. North America Rotavirus Vaccines Sales Market Share by Application (2017-2028)
    Figure 39. North America Rotavirus Vaccines Revenue Market Share by Application (2017-2028)
    Figure 40. North America Rotavirus Vaccines Sales Share by Country (2017-2028)
    Figure 41. North America Rotavirus Vaccines Revenue Share by Country (2017-2028)
    Figure 42. U.S. Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Rotavirus Vaccines Sales Market Share by Type (2017-2028)
    Figure 45. Europe Rotavirus Vaccines Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Rotavirus Vaccines Sales Market Share by Application (2017-2028)
    Figure 47. Europe Rotavirus Vaccines Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Rotavirus Vaccines Sales Share by Country (2017-2028)
    Figure 49. Europe Rotavirus Vaccines Revenue Share by Country (2017-2028)
    Figure 50. Germany Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. France Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Rotavirus Vaccines Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Rotavirus Vaccines Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Rotavirus Vaccines Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Rotavirus Vaccines Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Rotavirus Vaccines Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Rotavirus Vaccines Revenue Share by Region (2017-2028)
    Figure 61. China Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. India Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Rotavirus Vaccines Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Rotavirus Vaccines Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Rotavirus Vaccines Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Rotavirus Vaccines Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Rotavirus Vaccines Sales Share by Country (2017-2028)
    Figure 76. Latin America Rotavirus Vaccines Revenue Share by Country (2017-2028)
    Figure 77. Mexico Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Rotavirus Vaccines Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Rotavirus Vaccines Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Rotavirus Vaccines Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Rotavirus Vaccines Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Rotavirus Vaccines Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Rotavirus Vaccines Revenue Share by Country (2017-2028)
    Figure 86. Turkey Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Rotavirus Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 89. Rotavirus Vaccines Value Chain
    Figure 90. Rotavirus Vaccines Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Frequently Asked Questions
Rotavirus Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rotavirus Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rotavirus Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Tetanus Vaccine

Tetanus Vaccine market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

TB Vaccines

TB Vaccines market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Laboratory Mixers

Laboratory Mixers market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More